Page last updated: 2024-08-23

pefloxacin and Body Weight

pefloxacin has been researched along with Body Weight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fox, CL; Fox, P; Friedlaender, J; Modak, S; Stanford, J	1
Andremont, A; Carbon, C; Massias, L; Montravers, P	1

Other Studies

2 other study(ies) available for pefloxacin and Body Weight

Article	Year
Control of burn wound infections by pefloxacin and its silver derivative. Burns, including thermal injury, 1984, Volume: 10, Issue:3 Topics: Administration, Topical; Animals; Body Weight; Burns; Female; Mice; Nalidixic Acid; Pefloxacin; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Time Factors; Tissue Distribution	1984
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. The Journal of infectious diseases, 1994, Volume: 169, Issue:4 Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms	1994

Article

Year

Control of burn wound infections by pefloxacin and its silver derivative.

Burns, including thermal injury, 1984, Volume: 10, Issue:3

Topics: Administration, Topical; Animals; Body Weight; Burns; Female; Mice; Nalidixic Acid; Pefloxacin; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Time Factors; Tissue Distribution

1984

Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.

The Journal of infectious diseases, 1994, Volume: 169, Issue:4

Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms

1994